Ticker

No recent analyst price targets found for BMRA.

Latest News for BMRA

Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development

Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient,…

GlobeNewsWire • May 28, 2026
Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago

GlobeNewsWire • Apr 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for BMRA.

No House trades found for BMRA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top